(1)
Humani, T. S.; Sutari, S.; Triningsih, T.; Ramli, M.; Ritawidya, R.; Haryuni, R. D. Preparation of (177Lu-DOTA)n-PAMAM-[Nimotuzumab-F(ab’)2] As a Therapeutic Radioimmunoconjugate for EGFR Overexpressed Cancers Treatment. J. Math. Fund. Sci. 2017, 49, 258-268.